nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.109	0.136	CbGbCtD
Cefepime—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0974	0.121	CbGbCtD
Cefepime—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0941	0.117	CbGbCtD
Cefepime—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0868	0.108	CbGbCtD
Cefepime—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0839	0.104	CbGbCtD
Cefepime—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0828	0.103	CbGbCtD
Cefepime—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0748	0.0929	CbGbCtD
Cefepime—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0713	0.0886	CbGbCtD
Cefepime—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0559	0.0695	CbGbCtD
Cefepime—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0482	0.0599	CbGbCtD
Cefepime—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000233	0.00122	CcSEcCtD
Cefepime—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000233	0.00122	CcSEcCtD
Cefepime—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000233	0.00122	CcSEcCtD
Cefepime—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000232	0.00121	CcSEcCtD
Cefepime—Bronchitis—Ramipril—type 2 diabetes mellitus	0.00023	0.00121	CcSEcCtD
Cefepime—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000229	0.0012	CcSEcCtD
Cefepime—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000229	0.0012	CcSEcCtD
Cefepime—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000228	0.00119	CcSEcCtD
Cefepime—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000228	0.00119	CcSEcCtD
Cefepime—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000228	0.00119	CcSEcCtD
Cefepime—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000228	0.00119	CcSEcCtD
Cefepime—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000227	0.00119	CcSEcCtD
Cefepime—Chills—Metformin—type 2 diabetes mellitus	0.000226	0.00118	CcSEcCtD
Cefepime—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00118	CcSEcCtD
Cefepime—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000224	0.00117	CcSEcCtD
Cefepime—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000223	0.00117	CcSEcCtD
Cefepime—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00117	CcSEcCtD
Cefepime—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000223	0.00116	CcSEcCtD
Cefepime—Nausea—Repaglinide—type 2 diabetes mellitus	0.000222	0.00116	CcSEcCtD
Cefepime—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000221	0.00116	CcSEcCtD
Cefepime—Erythema—Metformin—type 2 diabetes mellitus	0.000219	0.00115	CcSEcCtD
Cefepime—Pruritus—Glipizide—type 2 diabetes mellitus	0.000219	0.00115	CcSEcCtD
Cefepime—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000218	0.00114	CcSEcCtD
Cefepime—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000216	0.00113	CcSEcCtD
Cefepime—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000215	0.00112	CcSEcCtD
Cefepime—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00112	CcSEcCtD
Cefepime—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000214	0.00112	CcSEcCtD
Cefepime—Chills—Irbesartan—type 2 diabetes mellitus	0.000213	0.00112	CcSEcCtD
Cefepime—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000213	0.00111	CcSEcCtD
Cefepime—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000213	0.00111	CcSEcCtD
Cefepime—Infection—Gliclazide—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Cefepime—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Cefepime—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Cefepime—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Cefepime—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Cefepime—Renal failure—Ramipril—type 2 diabetes mellitus	0.00021	0.0011	CcSEcCtD
Cefepime—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00021	0.0011	CcSEcCtD
Cefepime—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000209	0.0011	CcSEcCtD
Cefepime—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000208	0.00109	CcSEcCtD
Cefepime—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00108	CcSEcCtD
Cefepime—Erythema—Irbesartan—type 2 diabetes mellitus	0.000207	0.00108	CcSEcCtD
Cefepime—Convulsion—Orlistat—type 2 diabetes mellitus	0.000206	0.00108	CcSEcCtD
Cefepime—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00108	CcSEcCtD
Cefepime—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00108	CcSEcCtD
Cefepime—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000206	0.00108	CcSEcCtD
Cefepime—Dizziness—Glipizide—type 2 diabetes mellitus	0.000205	0.00107	CcSEcCtD
Cefepime—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000204	0.00107	CcSEcCtD
Cefepime—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00106	CcSEcCtD
Cefepime—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000203	0.00106	CcSEcCtD
Cefepime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.0002	0.0497	CbGpPWpGaD
Cefepime—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000199	0.00104	CcSEcCtD
Cefepime—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000198	0.00103	CcSEcCtD
Cefepime—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00103	CcSEcCtD
Cefepime—Vomiting—Glipizide—type 2 diabetes mellitus	0.000197	0.00103	CcSEcCtD
Cefepime—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000197	0.00103	CcSEcCtD
Cefepime—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000196	0.00103	CcSEcCtD
Cefepime—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000196	0.00103	CcSEcCtD
Cefepime—Infection—Valsartan—type 2 diabetes mellitus	0.000195	0.00102	CcSEcCtD
Cefepime—Rash—Glipizide—type 2 diabetes mellitus	0.000195	0.00102	CcSEcCtD
Cefepime—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000195	0.00102	CcSEcCtD
Cefepime—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000195	0.00102	CcSEcCtD
Cefepime—Erythema—Losartan—type 2 diabetes mellitus	0.000195	0.00102	CcSEcCtD
Cefepime—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Cefepime—Headache—Glipizide—type 2 diabetes mellitus	0.000194	0.00101	CcSEcCtD
Cefepime—Shock—Valsartan—type 2 diabetes mellitus	0.000193	0.00101	CcSEcCtD
Cefepime—Infection—Orlistat—type 2 diabetes mellitus	0.000193	0.00101	CcSEcCtD
Cefepime—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000192	0.00101	CcSEcCtD
Cefepime—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000192	0.001	CcSEcCtD
Cefepime—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000191	0.001	CcSEcCtD
Cefepime—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000191	0.000999	CcSEcCtD
Cefepime—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000191	0.000997	CcSEcCtD
Cefepime—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000191	0.000997	CcSEcCtD
Cefepime—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00019	0.000996	CcSEcCtD
Cefepime—Agitation—Irbesartan—type 2 diabetes mellitus	0.00019	0.000994	CcSEcCtD
Cefepime—Urticaria—Glyburide—type 2 diabetes mellitus	0.000189	0.00099	CcSEcCtD
Cefepime—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000188	0.000985	CcSEcCtD
Cefepime—Headache—Pioglitazone—type 2 diabetes mellitus	0.000186	0.000971	CcSEcCtD
Cefepime—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000185	0.000969	CcSEcCtD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000185	0.0461	CbGpPWpGaD
Cefepime—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000185	0.000966	CcSEcCtD
Cefepime—Nausea—Glipizide—type 2 diabetes mellitus	0.000184	0.000961	CcSEcCtD
Cefepime—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000184	0.00096	CcSEcCtD
Cefepime—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000183	0.000957	CcSEcCtD
Cefepime—Pain—Gliclazide—type 2 diabetes mellitus	0.000183	0.000956	CcSEcCtD
Cefepime—Constipation—Gliclazide—type 2 diabetes mellitus	0.000183	0.000956	CcSEcCtD
Cefepime—Rash—Glimepiride—type 2 diabetes mellitus	0.000182	0.000952	CcSEcCtD
Cefepime—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000182	0.000951	CcSEcCtD
Cefepime—Rash—Sitagliptin—type 2 diabetes mellitus	0.000182	0.000949	CcSEcCtD
Cefepime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000181	0.000948	CcSEcCtD
Cefepime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000181	0.000948	CcSEcCtD
Cefepime—Headache—Glimepiride—type 2 diabetes mellitus	0.000181	0.000946	CcSEcCtD
Cefepime—Headache—Sitagliptin—type 2 diabetes mellitus	0.00018	0.000943	CcSEcCtD
Cefepime—Anaemia—Losartan—type 2 diabetes mellitus	0.00018	0.000941	CcSEcCtD
Cefepime—Agitation—Losartan—type 2 diabetes mellitus	0.000179	0.000936	CcSEcCtD
Cefepime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000178	0.000932	CcSEcCtD
Cefepime—Infection—Metformin—type 2 diabetes mellitus	0.000178	0.00093	CcSEcCtD
Cefepime—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000176	0.000923	CcSEcCtD
Cefepime—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000176	0.000922	CcSEcCtD
Cefepime—Shock—Metformin—type 2 diabetes mellitus	0.000176	0.000921	CcSEcCtD
Cefepime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000175	0.000918	CcSEcCtD
Cefepime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000175	0.000916	CcSEcCtD
Cefepime—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000175	0.000916	CcSEcCtD
Cefepime—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000175	0.000915	CcSEcCtD
Cefepime—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000174	0.000912	CcSEcCtD
Cefepime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000174	0.000912	CcSEcCtD
Cefepime—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000172	0.000901	CcSEcCtD
Cefepime—Nausea—Glimepiride—type 2 diabetes mellitus	0.000172	0.000897	CcSEcCtD
Cefepime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000171	0.000894	CcSEcCtD
Cefepime—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00017	0.000889	CcSEcCtD
Cefepime—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00017	0.000887	CcSEcCtD
Cefepime—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000169	0.000884	CcSEcCtD
Cefepime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000169	0.000884	CcSEcCtD
Cefepime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000169	0.000883	CcSEcCtD
Cefepime—Pruritus—Glyburide—type 2 diabetes mellitus	0.000169	0.000881	CcSEcCtD
Cefepime—Constipation—Valsartan—type 2 diabetes mellitus	0.000168	0.000879	CcSEcCtD
Cefepime—Infection—Irbesartan—type 2 diabetes mellitus	0.000168	0.000877	CcSEcCtD
Cefepime—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000168	0.000877	CcSEcCtD
Cefepime—Erythema—Ramipril—type 2 diabetes mellitus	0.000167	0.000873	CcSEcCtD
Cefepime—Shock—Irbesartan—type 2 diabetes mellitus	0.000166	0.000869	CcSEcCtD
Cefepime—Pain—Orlistat—type 2 diabetes mellitus	0.000166	0.000868	CcSEcCtD
Cefepime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000166	0.000866	CcSEcCtD
Cefepime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000165	0.000865	CcSEcCtD
Cefepime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000164	0.000859	CcSEcCtD
Cefepime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000164	0.000858	CcSEcCtD
Cefepime—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000164	0.000855	CcSEcCtD
Cefepime—Headache—Bromocriptine—type 2 diabetes mellitus	0.000163	0.000854	CcSEcCtD
Cefepime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000163	0.000852	CcSEcCtD
Cefepime—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000161	0.00084	CcSEcCtD
Cefepime—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000161	0.00084	CcSEcCtD
Cefepime—Confusional state—Losartan—type 2 diabetes mellitus	0.00016	0.000838	CcSEcCtD
Cefepime—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00016	0.000837	CcSEcCtD
Cefepime—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00016	0.000834	CcSEcCtD
Cefepime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000159	0.000831	CcSEcCtD
Cefepime—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000159	0.00083	CcSEcCtD
Cefepime—Infection—Losartan—type 2 diabetes mellitus	0.000158	0.000826	CcSEcCtD
Cefepime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000158	0.000824	CcSEcCtD
Cefepime—Shock—Losartan—type 2 diabetes mellitus	0.000156	0.000818	CcSEcCtD
Cefepime—Urticaria—Valsartan—type 2 diabetes mellitus	0.000156	0.000816	CcSEcCtD
Cefepime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000156	0.000814	CcSEcCtD
Cefepime—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000155	0.000812	CcSEcCtD
Cefepime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000155	0.000809	CcSEcCtD
Cefepime—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000154	0.000808	CcSEcCtD
Cefepime—Urticaria—Orlistat—type 2 diabetes mellitus	0.000154	0.000807	CcSEcCtD
Cefepime—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000153	0.000803	CcSEcCtD
Cefepime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000153	0.000803	CcSEcCtD
Cefepime—Agitation—Ramipril—type 2 diabetes mellitus	0.000153	0.000802	CcSEcCtD
Cefepime—Constipation—Metformin—type 2 diabetes mellitus	0.000153	0.0008	CcSEcCtD
Cefepime—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000152	0.000793	CcSEcCtD
Cefepime—Vomiting—Glyburide—type 2 diabetes mellitus	0.000151	0.000792	CcSEcCtD
Cefepime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000151	0.000791	CcSEcCtD
Cefepime—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000151	0.000787	CcSEcCtD
Cefepime—Rash—Glyburide—type 2 diabetes mellitus	0.00015	0.000785	CcSEcCtD
Cefepime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00015	0.000785	CcSEcCtD
Cefepime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000149	0.000782	CcSEcCtD
Cefepime—Headache—Glyburide—type 2 diabetes mellitus	0.000149	0.00078	CcSEcCtD
Cefepime—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000147	0.000771	CcSEcCtD
Cefepime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000146	0.000765	CcSEcCtD
Cefepime—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000146	0.000765	CcSEcCtD
Cefepime—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000146	0.000762	CcSEcCtD
Cefepime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000145	0.000757	CcSEcCtD
Cefepime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000145	0.000757	CcSEcCtD
Cefepime—Pain—Irbesartan—type 2 diabetes mellitus	0.000144	0.000755	CcSEcCtD
Cefepime—Constipation—Irbesartan—type 2 diabetes mellitus	0.000144	0.000755	CcSEcCtD
Cefepime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000143	0.000748	CcSEcCtD
Cefepime—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000143	0.000746	CcSEcCtD
Cefepime—Urticaria—Metformin—type 2 diabetes mellitus	0.000142	0.000743	CcSEcCtD
Cefepime—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000142	0.000741	CcSEcCtD
Cefepime—Nausea—Glyburide—type 2 diabetes mellitus	0.000141	0.00074	CcSEcCtD
Cefepime—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000141	0.00074	CcSEcCtD
Cefepime—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000141	0.00074	CcSEcCtD
Cefepime—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000139	0.000728	CcSEcCtD
Cefepime—Pruritus—Valsartan—type 2 diabetes mellitus	0.000139	0.000727	CcSEcCtD
Cefepime—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000138	0.000722	CcSEcCtD
Cefepime—Confusional state—Ramipril—type 2 diabetes mellitus	0.000137	0.000719	CcSEcCtD
Cefepime—Pruritus—Orlistat—type 2 diabetes mellitus	0.000137	0.000718	CcSEcCtD
Cefepime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000136	0.000713	CcSEcCtD
Cefepime—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000136	0.000711	CcSEcCtD
Cefepime—Constipation—Losartan—type 2 diabetes mellitus	0.000136	0.000711	CcSEcCtD
Cefepime—Pain—Losartan—type 2 diabetes mellitus	0.000136	0.000711	CcSEcCtD
Cefepime—Rash—Gliclazide—type 2 diabetes mellitus	0.000135	0.000705	CcSEcCtD
Cefepime—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000135	0.000705	CcSEcCtD
Cefepime—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000134	0.000703	CcSEcCtD
Cefepime—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000134	0.000702	CcSEcCtD
Cefepime—Shock—Ramipril—type 2 diabetes mellitus	0.000134	0.000701	CcSEcCtD
Cefepime—Headache—Gliclazide—type 2 diabetes mellitus	0.000134	0.000701	CcSEcCtD
Cefepime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000133	0.000698	CcSEcCtD
Cefepime—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000133	0.000698	CcSEcCtD
Cefepime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000133	0.000698	CcSEcCtD
Cefepime—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000133	0.000695	CcSEcCtD
Cefepime—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000131	0.000685	CcSEcCtD
Cefepime—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00013	0.00068	CcSEcCtD
Cefepime—Dizziness—Valsartan—type 2 diabetes mellitus	0.00013	0.00068	CcSEcCtD
Cefepime—Dizziness—Orlistat—type 2 diabetes mellitus	0.000128	0.000671	CcSEcCtD
Cefepime—Nausea—Gliclazide—type 2 diabetes mellitus	0.000127	0.000664	CcSEcCtD
Cefepime—Pruritus—Metformin—type 2 diabetes mellitus	0.000127	0.000662	CcSEcCtD
Cefepime—Urticaria—Losartan—type 2 diabetes mellitus	0.000126	0.00066	CcSEcCtD
Cefepime—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000126	0.000657	CcSEcCtD
Cefepime—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000126	0.000657	CcSEcCtD
Cefepime—Vomiting—Valsartan—type 2 diabetes mellitus	0.000125	0.000653	CcSEcCtD
Cefepime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000124	0.000651	CcSEcCtD
Cefepime—Rash—Valsartan—type 2 diabetes mellitus	0.000124	0.000648	CcSEcCtD
Cefepime—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000124	0.000647	CcSEcCtD
Cefepime—Vomiting—Orlistat—type 2 diabetes mellitus	0.000123	0.000646	CcSEcCtD
Cefepime—Headache—Valsartan—type 2 diabetes mellitus	0.000123	0.000644	CcSEcCtD
Cefepime—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000122	0.00064	CcSEcCtD
Cefepime—Rash—Orlistat—type 2 diabetes mellitus	0.000122	0.00064	CcSEcCtD
Cefepime—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000122	0.00064	CcSEcCtD
Cefepime—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000122	0.00064	CcSEcCtD
Cefepime—Headache—Orlistat—type 2 diabetes mellitus	0.000122	0.000636	CcSEcCtD
Cefepime—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000121	0.000635	CcSEcCtD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000119	0.0298	CbGpPWpGaD
Cefepime—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000119	0.000625	CcSEcCtD
Cefepime—Dizziness—Metformin—type 2 diabetes mellitus	0.000118	0.000619	CcSEcCtD
Cefepime—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000118	0.000615	CcSEcCtD
Cefepime—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000117	0.000612	CcSEcCtD
Cefepime—Nausea—Valsartan—type 2 diabetes mellitus	0.000117	0.00061	CcSEcCtD
Cefepime—Constipation—Ramipril—type 2 diabetes mellitus	0.000117	0.000609	CcSEcCtD
Cefepime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000604	CcSEcCtD
Cefepime—Nausea—Orlistat—type 2 diabetes mellitus	0.000115	0.000603	CcSEcCtD
Cefepime—Vomiting—Metformin—type 2 diabetes mellitus	0.000114	0.000595	CcSEcCtD
Cefepime—Rash—Metformin—type 2 diabetes mellitus	0.000113	0.00059	CcSEcCtD
Cefepime—Dermatitis—Metformin—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Cefepime—Pruritus—Losartan—type 2 diabetes mellitus	0.000112	0.000588	CcSEcCtD
Cefepime—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000112	0.000587	CcSEcCtD
Cefepime—Headache—Metformin—type 2 diabetes mellitus	0.000112	0.000586	CcSEcCtD
Cefepime—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000112	0.000584	CcSEcCtD
Cefepime—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000111	0.000583	CcSEcCtD
Cefepime—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000109	0.000569	CcSEcCtD
Cefepime—Urticaria—Ramipril—type 2 diabetes mellitus	0.000108	0.000566	CcSEcCtD
Cefepime—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000108	0.000563	CcSEcCtD
Cefepime—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000108	0.000563	CcSEcCtD
Cefepime—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000107	0.000562	CcSEcCtD
Cefepime—Rash—Irbesartan—type 2 diabetes mellitus	0.000106	0.000557	CcSEcCtD
Cefepime—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000556	CcSEcCtD
Cefepime—Nausea—Metformin—type 2 diabetes mellitus	0.000106	0.000556	CcSEcCtD
Cefepime—Headache—Irbesartan—type 2 diabetes mellitus	0.000106	0.000553	CcSEcCtD
Cefepime—Dizziness—Losartan—type 2 diabetes mellitus	0.000105	0.00055	CcSEcCtD
Cefepime—Vomiting—Losartan—type 2 diabetes mellitus	0.000101	0.000528	CcSEcCtD
Cefepime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.0001	0.000525	CcSEcCtD
Cefepime—Nausea—Irbesartan—type 2 diabetes mellitus	0.0001	0.000525	CcSEcCtD
Cefepime—Rash—Losartan—type 2 diabetes mellitus	0.0001	0.000524	CcSEcCtD
Cefepime—Dermatitis—Losartan—type 2 diabetes mellitus	0.0001	0.000524	CcSEcCtD
Cefepime—Headache—Losartan—type 2 diabetes mellitus	9.96e-05	0.000521	CcSEcCtD
Cefepime—Pruritus—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000504	CcSEcCtD
Cefepime—Nausea—Losartan—type 2 diabetes mellitus	9.44e-05	0.000494	CcSEcCtD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	9.41e-05	0.0234	CbGpPWpGaD
Cefepime—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000488	CcSEcCtD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	9.06e-05	0.0226	CbGpPWpGaD
Cefepime—Dizziness—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000471	CcSEcCtD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.92e-05	0.0222	CbGpPWpGaD
Cefepime—Vomiting—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000453	CcSEcCtD
Cefepime—Rash—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000449	CcSEcCtD
Cefepime—Dermatitis—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000449	CcSEcCtD
Cefepime—Headache—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000446	CcSEcCtD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.27e-05	0.0206	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.14e-05	0.0203	CbGpPWpGaD
Cefepime—Nausea—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000423	CcSEcCtD
Cefepime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	6.42e-05	0.016	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	6.19e-05	0.0154	CbGpPWpGaD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	5.96e-05	0.0148	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.95e-05	0.0148	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.75e-05	0.0143	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.52e-05	0.0138	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.43e-05	0.0135	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.33e-05	0.0133	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.24e-05	0.0131	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.68e-05	0.0117	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	4.59e-05	0.0114	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.53e-05	0.0113	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.51e-05	0.0112	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.35e-05	0.0108	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.27e-05	0.0106	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.2e-05	0.0105	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.18e-05	0.0104	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.14e-05	0.0103	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.11e-05	0.0102	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.83e-05	0.00955	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.7e-05	0.00922	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.56e-05	0.00886	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.5e-05	0.00871	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.44e-05	0.00856	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.38e-05	0.00842	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.08e-05	0.00767	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.02e-05	0.00753	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.94e-05	0.00733	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.92e-05	0.00727	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.92e-05	0.00727	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.87e-05	0.00715	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.86e-05	0.00712	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.81e-05	0.007	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.81e-05	0.00699	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.76e-05	0.00687	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.73e-05	0.0068	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.71e-05	0.00675	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.71e-05	0.00675	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.68e-05	0.00669	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.67e-05	0.00665	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.66e-05	0.00664	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.66e-05	0.00664	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.66e-05	0.00664	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.62e-05	0.00653	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.48e-05	0.00617	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.44e-05	0.00607	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.39e-05	0.00594	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.38e-05	0.00593	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.38e-05	0.00593	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.29e-05	0.00571	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.29e-05	0.00571	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.29e-05	0.0057	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.25e-05	0.00561	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.21e-05	0.00551	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.21e-05	0.0055	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.21e-05	0.0055	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.18e-05	0.00542	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.17e-05	0.00541	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.17e-05	0.00541	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.13e-05	0.0053	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.13e-05	0.0053	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.12e-05	0.00529	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.09e-05	0.00521	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.09e-05	0.00521	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.09e-05	0.0052	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.09e-05	0.0052	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.08e-05	0.00518	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.05e-05	0.00512	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.95e-05	0.00485	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.94e-05	0.00484	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.93e-05	0.00481	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.9e-05	0.00473	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.88e-05	0.00469	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.81e-05	0.0045	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.8e-05	0.0045	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.8e-05	0.00449	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.78e-05	0.00443	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.78e-05	0.00442	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.75e-05	0.00435	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.72e-05	0.00428	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.67e-05	0.00417	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.65e-05	0.0041	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.57e-05	0.0039	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.49e-05	0.00372	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.49e-05	0.00372	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.46e-05	0.00363	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.45e-05	0.00362	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.45e-05	0.00361	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.44e-05	0.00359	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.43e-05	0.00356	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.39e-05	0.00345	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.39e-05	0.00345	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.36e-05	0.0034	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.36e-05	0.0034	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.35e-05	0.00337	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.35e-05	0.00335	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.34e-05	0.00333	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.33e-05	0.00332	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.32e-05	0.0033	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.32e-05	0.00328	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.27e-05	0.00317	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.21e-05	0.00302	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.18e-05	0.00294	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.18e-05	0.00293	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.16e-05	0.00289	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.16e-05	0.00289	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.13e-05	0.0028	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.11e-05	0.00276	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.09e-05	0.00272	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.08e-05	0.00269	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.08e-05	0.00268	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.06e-05	0.00264	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1e-05	0.0025	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.97e-06	0.00248	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.88e-06	0.00246	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.55e-06	0.00238	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.3e-06	0.00232	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.25e-06	0.00231	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.17e-06	0.00228	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.14e-06	0.00228	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.1e-06	0.00227	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.02e-06	0.00225	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.93e-06	0.00222	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.86e-06	0.00221	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.72e-06	0.00217	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.29e-06	0.00206	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.15e-06	0.00203	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.06e-06	0.00201	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.56e-06	0.00188	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.48e-06	0.00186	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.35e-06	0.00183	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.01e-06	0.00175	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.9e-06	0.00172	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.99e-06	0.00149	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.56e-06	0.00138	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.47e-06	0.00136	CbGpPWpGaD
